Evidence map›Paper›PMID 40952397›Full record

ArticleThe international journal of medical robotics + computer assisted surgery : MRCAS2025

Robotic Single-Port Versus Robotic Single-Site Hysterectomy in Early Endometrial Cancer: A Case Control Study.

Riccardo Vizza, Giacomo Corrado, Valentina Bruno, Ermelinda Baiocco, Pier Carlo Zorzato, Stefano Uccella, Enrico Vizza

Abstract readComparative Study
In one paragraph

Article in The international journal of medical robotics + computer assisted surgery : MRCAS, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Single+1 Port Robotic Splenectomy Using the da Vinci SP System-Experience of a Single Centre.The international journal of medical robotics + computer assisted surgery : MRCAS · 2026
    Article
  3. Article
  4. Robotic Single-Port Versus Robotic Single-Site Hysterectomy in Early Endometrial Cancer: A Case Control Study.The international journal of medical robotics + computer assisted surgery : MRCAS · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Riccardo VizzaDepartment of Obstetrics and Gynecology, AOUI Verona, University of Verona, Verona, Italy.ORCID https://orcid.org/0009-0000-7401-8965
Giacomo CorradoDipartimento Scienze della Salute della Donna, del Bambino e di Sanità Pubblica, UOC Ginecologia Oncologica, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy.
Valentina BrunoGynecologic Oncology Unit, Department of Experimental Clinical Oncology, IRCSS-Regina Elena National Cancer Unit Institute, Rome, Italy.
Ermelinda BaioccoGynecologic Oncology Unit, Department of Experimental Clinical Oncology, IRCSS-Regina Elena National Cancer Unit Institute, Rome, Italy.
Pier Carlo ZorzatoDepartment of Obstetrics and Gynecology, AOUI Verona, University of Verona, Verona, Italy.
Stefano UccellaDepartment of Obstetrics and Gynecology, AOUI Verona, University of Verona, Verona, Italy.
Enrico VizzaGynecologic Oncology Unit, Department of Experimental Clinical Oncology, IRCSS-Regina Elena National Cancer Unit Institute, Rome, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo compare surgical outcomes of robotic single-port (RSPH) versus single-site (RSSH) hysterectomy in early-stage endometrial cancer.

methodsThis is a retrospective case-control study, comparing surgical outcomes of RSPH (Cases) and RSSH (Controls) in early-stage endometrial cancer.

resultsTwenty-five women who underwent RSPH from June 2024 to November 2024 were matched with 50 historical RSSH controls treated at the same institution by the same surgical team between December 2011 and September 2014. Operation time was similar: 110 min in RSPH and 99 min in RSSH (p = 0.76). Blood loss was 50 mL in RSPH and 60 mL in RSSH (p = 0.14). Hospital stay was shorter in RSSH (3.5 days in RSPH and 3 days in RSSH, p = 0.001).

conclusionsOur study confirms the safety and feasibility of RSPH for endometrial cancer without major differences from the RSSH in terms of surgical outcomes.

Indexed as

Endometrial NeoplasmsHysterectomyRobotic Surgical ProceduresAdultAgedBlood Loss, SurgicalCase-Control StudiesFemaleHumansLength of StayMiddle AgedOperative TimeRetrospective StudiesTreatment OutcomeDa Vinci SProbotic hysterectomySP surgery

Identifiers

PMID40952397
PMCPMC12435414

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.